Germany Statistics - Revision history

Z8600021 at 23:57, 1 February 2020

2020-02-01T23:57:30Z

@@ Line 5: / Line 5: @@
 :{{Statistics Links}} | [[:Category:Germany|Category:Germany]]
-==Embryologists==
+==People==
 * Otto Leonhardt Heubner (1843-1926) was appointed to the first professorship in Germany exclusively devoted to pediatrics at the Charité Children's Clinic of Berlin University. He studied internal medicine in Leipzig under Carl Reinhold August Wunderlich and Ernst Leberecht Wagner, his early research involved anatomical studies of the circulation of the brain, from which he described syphilitic endarteritis (Heubner's disease) and the medial striate artery (recurrent artery of Heubner). He then with the Max Rubner, studied energy metabolism in infancy, creating the notion of the nutrition quotient.{{#pmid:11117858|PMID11117858}}

Z8600021 at 23:56, 1 February 2020

2020-02-01T23:56:39Z

← Older revision		Revision as of 10:56, 2 February 2020
Line 4:		Line 4:

	:{{Statistics Links}} \| [[:Category:Germany\|Category:Germany]]		:{{Statistics Links}} \| [[:Category:Germany\|Category:Germany]]

			==Embryologists==

			* Otto Leonhardt Heubner (1843-1926) was appointed to the first professorship in Germany exclusively devoted to pediatrics at the Charité Children's Clinic of Berlin University. He studied internal medicine in Leipzig under Carl Reinhold August Wunderlich and Ernst Leberecht Wagner, his early research involved anatomical studies of the circulation of the brain, from which he described syphilitic endarteritis (Heubner's disease) and the medial striate artery (recurrent artery of Heubner). He then with the Max Rubner, studied energy metabolism in infancy, creating the notion of the nutrition quotient.{{#pmid:11117858\|PMID11117858}}

	==Some Recent Findings==		==Some Recent Findings==

Z8600021 at 03:17, 23 Haziran 2019

2019-06-23T03:17:28Z

← Older revision		Revision as of 14:17, 23 Haziran 2019
Line 31:		Line 31:

	==General Statistics==		==General Statistics==
	* 81,~~471~~,~~834~~ (July ~~2011~~ est.)		* 80,457,737 (July 2018 est.)
	* country comparison to the world: 16		* country comparison to the world: 19

	===Age structure===		===Age structure===
			(2011 est.)

	* 0-14 years: 13.3% (male 5,569,390/female 5,282,245)		* 0-14 years: 13.3% (male 5,569,390/female 5,282,245)
	* 15-64 years: 66.1% (male 27,227,487/female 26,617,915)		* 15-64 years: 66.1% (male 27,227,487/female 26,617,915)
	* 65 years and over: 20.6% (male 7,217,163/female 9,557,634) ~~(2011 est.)~~		* 65 years and over: 20.6% (male 7,217,163/female 9,557,634)

	===Median age===		===Median age===
			(2011 est.)

	* total: 44.9 years		* total: 44.9 years
	* male: 43.7 years		* male: 43.7 years
	* female: 46 years ~~(2011 est.)~~		* female: 46 years
	===Population growth rate===		===Population growth rate===

Z8600021 at 03:08, 23 Haziran 2019

2019-06-23T03:08:02Z

← Older revision		Revision as of 14:08, 23 Haziran 2019
Line 88:		Line 88:

	Data: '''The World Factbook''' [https://www.cia.gov/library/publications/the-world-factbook/geos/gm.html Germany]		Data: '''The World Factbook''' [https://www.cia.gov/library/publications/the-world-factbook/geos/gm.html Germany]


			==References==
			<references/>

	==External Links==		==External Links==

Z8600021 at 03:26, 5 March 2019

2019-03-05T03:26:38Z

← Older revision		Revision as of 14:26, 5 March 2019
Line 9:		Line 9:
	\|-bgcolor="F5FAFF"		\|-bgcolor="F5FAFF"
	\|		\|
			* '''Variations of sex development: The first German interdisciplinary consensus paper'''{{#pmid:30713084\|PMID30713084}} "The term variations of sex development subsumes a large number of congenital conditions including chromosomal mosaics and variations of chromosomal, gonadal, and phenotypic sex. A situation of this nature may cause severe distress to both, parents and affected persons. One of the reasons for this is the binary form of gender classification in the society. In the past, because of a fear of possible stigmatization and an inability to cope with complex situations, it has been medical policy and practice for newborns to undergo early, mostly 'feminizing' elective surgery with the aim of achieving an outer genital appearance that is unambiguously male or female. Protests by advocacy groups for the most part as well as the results of outcome studies have shown that the development of affected persons may be very different to what has been expected and often does not result in the intended clear female or male gender identity as had been intended. CONCLUSION: The introduction of the consensus paper reflects on the emerging paradigm shift and the necessity for a more open view of gender within society. The paper is intended to aid the performance of appropriate diagnostics in DSD-affected newborns and especially to help parents and affected persons cope with the biological and social consequences of DSD. With regard to medical or surgical therapy, it gives information about the most recent treatment trends." {{genital abnormalities}}

	* '''DEGUM, ÖGUM, SGUM and FMF Germany Recommendations for the Implementation of First-Trimester Screening, Detailed Ultrasound, Cell-Free DNA Screening and Diagnostic Procedures'''{{#pmid:30001568\|PMID30001568}} " First-trimester screening between 11 + 0 and 13 + 6 weeks with qualified prenatal counseling, detailed {{ultrasound}}, biochemical markers and maternal factors has become the basis for decisions about further examinations. It detects numerous structural and genetic anomalies. The inclusion of uterine artery Doppler and PlGF screens for preeclampsia and fetal growth restriction. Low-dose aspirin significantly reduces the prevalence of severe preterm eclampsia. Cut-off values define groups of high, intermediate and low probability. Prenatal counseling uses detection and false-positive rates to work out the individual need profile and the corresponding decision: no further diagnosis/screening - cell-free DNA screening - diagnostic procedure and genetic analysis. In pre-test counseling it must be recognized that the prevalence of {{trisomy 21}}, 18 or 13 is low in younger women, as in submicroscopic anomalies in every maternal age. Even with high specificities, the positive predictive values of screening tests for rare anomalies are low. In the general population trisomies and sex chromosome aneuploidies account for approximately 70 % of anomalies recognizable by conventional genetic analysis. Screen positive results of cfDNA tests have to be proven by diagnostic procedure and genetic diagnosis. In cases of inconclusive results a higher rate of genetic anomalies is detected. Procedure-related fetal loss rates after chorionic biopsy and amniocentesis performed by experts are lower than 1 to 2 in 1000. Counseling should include the possible detection of submicroscopic anomalies by comparative genomic hybridization (array-CGH). At present, existing studies about screening for microdeletions and duplications do not provide reliable data to calculate sensitivities, false-positive rates and positive predictive values." {{ultrasound}}		* '''DEGUM, ÖGUM, SGUM and FMF Germany Recommendations for the Implementation of First-Trimester Screening, Detailed Ultrasound, Cell-Free DNA Screening and Diagnostic Procedures'''{{#pmid:30001568\|PMID30001568}} " First-trimester screening between 11 + 0 and 13 + 6 weeks with qualified prenatal counseling, detailed {{ultrasound}}, biochemical markers and maternal factors has become the basis for decisions about further examinations. It detects numerous structural and genetic anomalies. The inclusion of uterine artery Doppler and PlGF screens for preeclampsia and fetal growth restriction. Low-dose aspirin significantly reduces the prevalence of severe preterm eclampsia. Cut-off values define groups of high, intermediate and low probability. Prenatal counseling uses detection and false-positive rates to work out the individual need profile and the corresponding decision: no further diagnosis/screening - cell-free DNA screening - diagnostic procedure and genetic analysis. In pre-test counseling it must be recognized that the prevalence of {{trisomy 21}}, 18 or 13 is low in younger women, as in submicroscopic anomalies in every maternal age. Even with high specificities, the positive predictive values of screening tests for rare anomalies are low. In the general population trisomies and sex chromosome aneuploidies account for approximately 70 % of anomalies recognizable by conventional genetic analysis. Screen positive results of cfDNA tests have to be proven by diagnostic procedure and genetic diagnosis. In cases of inconclusive results a higher rate of genetic anomalies is detected. Procedure-related fetal loss rates after chorionic biopsy and amniocentesis performed by experts are lower than 1 to 2 in 1000. Counseling should include the possible detection of submicroscopic anomalies by comparative genomic hybridization (array-CGH). At present, existing studies about screening for microdeletions and duplications do not provide reliable data to calculate sensitivities, false-positive rates and positive predictive values." {{ultrasound}}
Line 16:		Line 17:
	! Older papers		! Older papers
	\|-		\|-
	\|		\| {{Older papers}}

	* '''Stillbirths in Germany 2003 - 2011'''{{#pmid:25901868\|PMID25901868}} "Searches in the international peer-reviewed literature, retrospective data collection of 168 stillbirths in 8 hospitals, (in the area of Bonn) with subsequent statistical evaluation (descriptive statistics, t-test and binominal test) were undertaken. This study shows considerable deficits in data documentation, interdisciplinary communication and postmortal examination. Only in 51.8% (87/168) of the cases was a certain or uncertain cause of death found (42.3% placental, 1.2% foetal, 3.6% chromosomal, 4.8% umbilical cord abnormalities). Severe foetal growth restriction (<5(th) percentile) was observed in 29.2%; 44.9% (22/49) of them died at the age of ≥36+0 weeks of gestation." [[Birth - Stillbirth and Perinatal Death]]		* '''Stillbirths in Germany 2003 - 2011'''{{#pmid:25901868\|PMID25901868}} "Searches in the international peer-reviewed literature, retrospective data collection of 168 stillbirths in 8 hospitals, (in the area of Bonn) with subsequent statistical evaluation (descriptive statistics, t-test and binominal test) were undertaken. This study shows considerable deficits in data documentation, interdisciplinary communication and postmortal examination. Only in 51.8% (87/168) of the cases was a certain or uncertain cause of death found (42.3% placental, 1.2% foetal, 3.6% chromosomal, 4.8% umbilical cord abnormalities). Severe foetal growth restriction (<5(th) percentile) was observed in 29.2%; 44.9% (22/49) of them died at the age of ≥36+0 weeks of gestation." [[Birth - Stillbirth and Perinatal Death]]

Z8600021 at 01:05, 23 July 2018

2018-07-23T01:05:05Z

← Older revision		Revision as of 12:05, 23 July 2018
Line 25:		Line 25:

	==Mean Age of Mothers==		==Mean Age of Mothers==
	~~{\| width=600px~~
	~~\|+ '''Mean age of mothers at the birth of live-born children'''~~
	~~\|-bgcolor="CEDFF2"~~
	~~\| Specification~~
	~~\| Unit~~
	~~\| 2006~~
	~~\| 2007~~
	~~\| 2008~~
	~~\| 2009~~
	\|-
	~~\| Total~~
	~~\| Age~~
	~~\| '''30.1'''~~
	~~\| '''30.3'''~~
	~~\| '''30.4'''~~
	~~\| '''30.4'''~~
	~~\|-bgcolor="CEDFF2"~~
	~~\| colspan="6" \|~~
	~~Married mothers (Referring to children from the present marriage)~~
	~~\|-bgcolor="F5FAFF"~~
	~~\| Total~~
	~~\| Age~~
	~~\| 31.1~~
	~~\| 31.2~~
	~~\| 31.3~~
	~~\| 31.4~~
	\|-
	~~\| At birth of first child~~
	~~\| Age~~
	~~\| 29.8~~
	~~\| 29.9~~
	~~\| 30.1~~
	~~\| 30,2~~
	~~\|-bgcolor="F5FAFF"~~
	~~\| At birth of second child~~
	~~\| Age~~
	~~\| 31.5~~
	~~\| 31.6~~
	~~\| 31.8~~
	~~\| 31,9~~
	\|-
	~~\| At birth of third child~~
	~~\| Age~~
	~~\| 32.9~~
	~~\| 33.0~~
	~~\| 33.2~~
	~~\| 33.3~~
	~~\|-bgcolor="F5FAFF"~~
	~~\| Unmarried mothers~~
	~~\| Age~~
	~~\| 28.0~~
	~~\| 28.2~~
	~~\| 28.3~~
	~~\| 28.5~~
	\|}

			{{Germany Mothers Age table1}}

	Source: [http://www.destatis.de/jetspeed/portal/cms/Sites/destatis/Internet/EN/Content/Statistics/Bevoelkerung/GeburtenSterbefaelle/Tabellen/Content75/BirthMotherAge,templateId=renderPrint.psml German Statistics]

	==General Statistics==		==General Statistics==

Z8600021 at 00:37, 23 July 2018

2018-07-23T00:37:34Z

← Older revision		Revision as of 11:37, 23 July 2018
Line 10:		Line 10:
	\|		\|

	* '''DEGUM, ÖGUM, SGUM and FMF Germany Recommendations for the Implementation of First-Trimester Screening, Detailed Ultrasound, Cell-Free DNA Screening and Diagnostic Procedures'''{{#pmid:30001568\|PMID30001568}} " First-trimester screening between 11 + 0 and 13 + 6 weeks with qualified prenatal counseling, detailed ultrasound, biochemical markers and maternal factors has become the basis for decisions about further examinations. It detects numerous structural and genetic anomalies. The inclusion of uterine artery Doppler and PlGF screens for preeclampsia and fetal growth restriction. Low-dose aspirin significantly reduces the prevalence of severe preterm eclampsia. Cut-off values define groups of high, intermediate and low probability. Prenatal counseling uses detection and false-positive rates to work out the individual need profile and the corresponding decision: no further diagnosis/screening - cell-free DNA screening - diagnostic procedure and genetic analysis. In pre-test counseling it must be recognized that the prevalence of trisomy 21, 18 or 13 is low in younger women, as in submicroscopic anomalies in every maternal age. Even with high specificities, the positive predictive values of screening tests for rare anomalies are low. In the general population trisomies and sex chromosome aneuploidies account for approximately 70 % of anomalies recognizable by conventional genetic analysis. Screen positive results of cfDNA tests have to be proven by diagnostic procedure and genetic diagnosis. In cases of inconclusive results a higher rate of genetic anomalies is detected. Procedure-related fetal loss rates after chorionic biopsy and amniocentesis performed by experts are lower than 1 to 2 in 1000. Counseling should include the possible detection of submicroscopic anomalies by comparative genomic hybridization (array-CGH). At present, existing studies about screening for microdeletions and duplications do not provide reliable data to calculate sensitivities, false-positive rates and positive predictive values.:		* '''DEGUM, ÖGUM, SGUM and FMF Germany Recommendations for the Implementation of First-Trimester Screening, Detailed Ultrasound, Cell-Free DNA Screening and Diagnostic Procedures'''{{#pmid:30001568\|PMID30001568}} " First-trimester screening between 11 + 0 and 13 + 6 weeks with qualified prenatal counseling, detailed {{ultrasound}}, biochemical markers and maternal factors has become the basis for decisions about further examinations. It detects numerous structural and genetic anomalies. The inclusion of uterine artery Doppler and PlGF screens for preeclampsia and fetal growth restriction. Low-dose aspirin significantly reduces the prevalence of severe preterm eclampsia. Cut-off values define groups of high, intermediate and low probability. Prenatal counseling uses detection and false-positive rates to work out the individual need profile and the corresponding decision: no further diagnosis/screening - cell-free DNA screening - diagnostic procedure and genetic analysis. In pre-test counseling it must be recognized that the prevalence of {{trisomy 21}}, 18 or 13 is low in younger women, as in submicroscopic anomalies in every maternal age. Even with high specificities, the positive predictive values of screening tests for rare anomalies are low. In the general population trisomies and sex chromosome aneuploidies account for approximately 70 % of anomalies recognizable by conventional genetic analysis. Screen positive results of cfDNA tests have to be proven by diagnostic procedure and genetic diagnosis. In cases of inconclusive results a higher rate of genetic anomalies is detected. Procedure-related fetal loss rates after chorionic biopsy and amniocentesis performed by experts are lower than 1 to 2 in 1000. Counseling should include the possible detection of submicroscopic anomalies by comparative genomic hybridization (array-CGH). At present, existing studies about screening for microdeletions and duplications do not provide reliable data to calculate sensitivities, false-positive rates and positive predictive values." {{ultrasound}}
	\|}		\|}

Z8600021 at 00:36, 23 July 2018

2018-07-23T00:36:05Z

← Older revision		Revision as of 11:36, 23 July 2018
Line 9:		Line 9:
	\|-bgcolor="F5FAFF"		\|-bgcolor="F5FAFF"
	\|		\|
	'''Stillbirths in Germany 2003 - 2011'''~~<ref name="~~PMID25901868"~~><pubmed>25901868</pubmed></ref>~~ Searches in the international peer-reviewed literature, retrospective data collection of 168 stillbirths in 8 hospitals, (in the area of Bonn) with subsequent statistical evaluation (descriptive statistics, t-test and binominal test) were undertaken. This study shows considerable deficits in data documentation, interdisciplinary communication and postmortal examination. Only in 51.8% (87/168) of the cases was a certain or uncertain cause of death found (42.3% placental, 1.2% foetal, 3.6% chromosomal, 4.8% umbilical cord abnormalities). Severe foetal growth restriction (<5(th) percentile) was observed in 29.2%; 44.9% (22/49) of them died at the age of ≥36+0 weeks of gestation." [[Birth - Stillbirth and Perinatal Death]]
			* '''DEGUM, ÖGUM, SGUM and FMF Germany Recommendations for the Implementation of First-Trimester Screening, Detailed Ultrasound, Cell-Free DNA Screening and Diagnostic Procedures'''{{#pmid:30001568\|PMID30001568}} " First-trimester screening between 11 + 0 and 13 + 6 weeks with qualified prenatal counseling, detailed ultrasound, biochemical markers and maternal factors has become the basis for decisions about further examinations. It detects numerous structural and genetic anomalies. The inclusion of uterine artery Doppler and PlGF screens for preeclampsia and fetal growth restriction. Low-dose aspirin significantly reduces the prevalence of severe preterm eclampsia. Cut-off values define groups of high, intermediate and low probability. Prenatal counseling uses detection and false-positive rates to work out the individual need profile and the corresponding decision: no further diagnosis/screening - cell-free DNA screening - diagnostic procedure and genetic analysis. In pre-test counseling it must be recognized that the prevalence of trisomy 21, 18 or 13 is low in younger women, as in submicroscopic anomalies in every maternal age. Even with high specificities, the positive predictive values of screening tests for rare anomalies are low. In the general population trisomies and sex chromosome aneuploidies account for approximately 70 % of anomalies recognizable by conventional genetic analysis. Screen positive results of cfDNA tests have to be proven by diagnostic procedure and genetic diagnosis. In cases of inconclusive results a higher rate of genetic anomalies is detected. Procedure-related fetal loss rates after chorionic biopsy and amniocentesis performed by experts are lower than 1 to 2 in 1000. Counseling should include the possible detection of submicroscopic anomalies by comparative genomic hybridization (array-CGH). At present, existing studies about screening for microdeletions and duplications do not provide reliable data to calculate sensitivities, false-positive rates and positive predictive values.:
			\|}

			{\| class="wikitable mw-collapsible mw-collapsed"
			! Older papers
			\|-
			\|

			* '''Stillbirths in Germany 2003 - 2011'''{{#pmid:25901868\|PMID25901868}} "Searches in the international peer-reviewed literature, retrospective data collection of 168 stillbirths in 8 hospitals, (in the area of Bonn) with subsequent statistical evaluation (descriptive statistics, t-test and binominal test) were undertaken. This study shows considerable deficits in data documentation, interdisciplinary communication and postmortal examination. Only in 51.8% (87/168) of the cases was a certain or uncertain cause of death found (42.3% placental, 1.2% foetal, 3.6% chromosomal, 4.8% umbilical cord abnormalities). Severe foetal growth restriction (<5(th) percentile) was observed in 29.2%; 44.9% (22/49) of them died at the age of ≥36+0 weeks of gestation." [[Birth - Stillbirth and Perinatal Death]]

	\|}		\|}
	==Germany - Total Fertility Rate==		==Germany - Total Fertility Rate==

Z8600021 at 04:10, 27 April 2015

2015-04-27T04:10:31Z

← Older revision		Revision as of 15:10, 27 April 2015
Line 5:		Line 5:
	:{{Statistics Links}} \| [[:Category:Germany\|Category:Germany]]		:{{Statistics Links}} \| [[:Category:Germany\|Category:Germany]]

			==Some Recent Findings==
			{\|
			\|-bgcolor="F5FAFF"
			\|
			'''Stillbirths in Germany 2003 - 2011'''<ref name="PMID25901868"><pubmed>25901868</pubmed></ref> Searches in the international peer-reviewed literature, retrospective data collection of 168 stillbirths in 8 hospitals, (in the area of Bonn) with subsequent statistical evaluation (descriptive statistics, t-test and binominal test) were undertaken. This study shows considerable deficits in data documentation, interdisciplinary communication and postmortal examination. Only in 51.8% (87/168) of the cases was a certain or uncertain cause of death found (42.3% placental, 1.2% foetal, 3.6% chromosomal, 4.8% umbilical cord abnormalities). Severe foetal growth restriction (<5(th) percentile) was observed in 29.2%; 44.9% (22/49) of them died at the age of ≥36+0 weeks of gestation." [[Birth - Stillbirth and Perinatal Death]]
			\|}
	==Germany - Total Fertility Rate==		==Germany - Total Fertility Rate==
	[[File:Germany fertility rate graph.jpg]]		[[File:Germany fertility rate graph.jpg]]

Z8600021 at 04:07, 14 March 2015

2015-03-14T04:07:52Z

← Older revision		Revision as of 15:07, 14 March 2015
Line 135:		Line 135:


	[[Category:Statistics]] [[Category:Birth]] [[Category:Germany]] [[Category:Europe]]		[[Category:Statistics]][[Category:Country]][[Category:Birth]] [[Category:Germany]] [[Category:Europe]]

	{{Glossary}}		{{Glossary}}

← Older revision		Revision as of 12:05, 23 July 2018
Line 25:		Line 25:

	==Mean Age of Mothers==		==Mean Age of Mothers==
	~~{\| width=600px~~
	~~\|+ '''Mean age of mothers at the birth of live-born children'''~~
	~~\|-bgcolor="CEDFF2"~~
	~~\| Specification~~
	~~\| Unit~~
	~~\| 2006~~
	~~\| 2007~~
	~~\| 2008~~
	~~\| 2009~~
	\|-
	~~\| Total~~
	~~\| Age~~
	~~\| '''30.1'''~~
	~~\| '''30.3'''~~
	~~\| '''30.4'''~~
	~~\| '''30.4'''~~
	~~\|-bgcolor="CEDFF2"~~
	~~\| colspan="6" \|~~
	~~Married mothers (Referring to children from the present marriage)~~
	~~\|-bgcolor="F5FAFF"~~
	~~\| Total~~
	~~\| Age~~
	~~\| 31.1~~
	~~\| 31.2~~
	~~\| 31.3~~
	~~\| 31.4~~
	\|-
	~~\| At birth of first child~~
	~~\| Age~~
	~~\| 29.8~~
	~~\| 29.9~~
	~~\| 30.1~~
	~~\| 30,2~~
	~~\|-bgcolor="F5FAFF"~~
	~~\| At birth of second child~~
	~~\| Age~~
	~~\| 31.5~~
	~~\| 31.6~~
	~~\| 31.8~~
	~~\| 31,9~~
	\|-
	~~\| At birth of third child~~
	~~\| Age~~
	~~\| 32.9~~
	~~\| 33.0~~
	~~\| 33.2~~
	~~\| 33.3~~
	~~\|-bgcolor="F5FAFF"~~
	~~\| Unmarried mothers~~
	~~\| Age~~
	~~\| 28.0~~
	~~\| 28.2~~
	~~\| 28.3~~
	~~\| 28.5~~
	\|}

			{{Germany Mothers Age table1}}

	Source: [http://www.destatis.de/jetspeed/portal/cms/Sites/destatis/Internet/EN/Content/Statistics/Bevoelkerung/GeburtenSterbefaelle/Tabellen/Content75/BirthMotherAge,templateId=renderPrint.psml German Statistics]

	==General Statistics==		==General Statistics==